Structural Analysis of the DAP5 MIF4G Domain and Its Interaction with Eif4a

Total Page:16

File Type:pdf, Size:1020Kb

Structural Analysis of the DAP5 MIF4G Domain and Its Interaction with Eif4a Structural Analysis of the DAP5 MIF4G Domain and Its Interaction with eIF4A Geneviève Virgili Department of Biochemistry Groupe de Recherche Axé sur la Structure des Protéines (GRASP) McGill University Montreal, QC April 2013 ________________________________________________________________________ A thesis submitted to McGill University in partial fulfillment of the requirements of the degree of Master of Science under the Faculty of Medicine © GENEVIÈVE VIRGILI, 2013 Never trust an atom. They make up everything. - Unknown author ii List of abbreviations 4E-BP eIF4E binding-protein ATP adenosine triphosphate ATPase adenosine triphosphatase Bcl B cell lymphoma CBP80 cap-binding protein 80 CHESS Cornell high energy synchrotron source Csk casein kinase CDK1 cyclin-dependent kinase 1 DAP5M MIF4G domain of DAP5 DNA deoxyribonucleic acid DTT dithiothreitol eIF eukaryotic initiation factor EMCV encephalomyocarditis virus EMSA electrophoretic mobility shift assay Erk extracellular signal-regulated kinases GTP guanosine triphosphate HCV Hepatitis C virus HEAT Huntingtin, Elongation factor 3, A subunit of protein phosphatase 2A [PP2A], and Target of rapamycin IAP inhibitor of apoptosis protein IPTG isopropyl-β-D-thiogalactoside ITC isothermal titration calorimetry Met methionine (or methionyl) MIF4G middle domain of eIF4G mRNA messenger RNA mRNP mRNA-protein complex Mnk MAPK-interacting kinase mTOR mammalian target of rapamycin NOM1 nucleolar MIF4G domain-containing protein 1 NOT1 negative regulator of transcription subunit 1 iii ORF open reading frame PABP poly(A) binding protein Paip1 PABP-interacting protein 1 PDB Protein Data Bank Pdcd4 programmed cell death protein 4 PI3K phosphatidylinositol 3-OH kinase PIC pre-initiation complex PKC protein kinase C PKR protein kinase double-stranded RNA-dependent PMSF phenylmethylsulfonyl fluoride RENT2 regulator of nonsense transcripts 2, also known as Upf2 RNA ribonucleic acid RRM RNA-recognition motif S6K ribosomal protein S6 kinase SAXS small-angle X-ray scattering SDS-PAGE sodium dodecyl sulfate-polyacrylamide gel electrophoresis Ser serine TC ternary complex TEV Tobacco Etch virus Thr threonine tRNA transfer RNA Met tRNAi initiator tRNA UTR untranslated region Val valine iv Abstract Death-associated protein 5 (DAP5/p97) is a homolog of the eukaryotic initiation factor 4G (eIF4G) that promotes the IRES-driven translation of multiple cellular mRNAs. Central to its function is the middle domain (MIF4G), which recruits the RNA helicase eIF4A. The middle domain of eIF4G consists of tandem HEAT repeats that coalesce to form a solenoid-type structure. Here, we report the crystal structure of the DAP5 MIF4G domain. Its overall fold is very similar to that of eIF4G, however, significant conformational variations impart distinct surface properties that could explain the observed differences in IRES binding between the two proteins. Interestingly, quantitative analysis of the DAP5-eIF4A interaction using isothermal titration calorimetry reveals a 10-fold lower affinity than with the eIF4G-eIF4A interaction that appears to affect their ability to stimulate eIF4A RNA unwinding activity in vitro. This difference in stability of the complex may have functional implications in selecting the mode of translation initiation. v Résumé Death-associated protein 5 (DAP5/p97) est une protéine homologue au facteur d'initiation eIF4G qui soutient la traduction d'ARN cellulaires contenant des éléments IRES chez les eukaryotes. Au centre de sa fonction est le domaine MIF4G, qui recrute l'ARN hélicase eIF4A. Ce domaine est constitué de motifs HEAT qui se répètent en tandem pour former une structure en forme de solénoïde. Nous rapportons ici la structure cristalline du domaine MIF4G de DAP5. Sa structure est très similaire à celle d’eIF4G. Toutefois, d'importantes variations de conformation lui confèrent des propriétés de surface distinctes qui pourraient expliquer les différences de liaison d'IRES observées entre les deux protéines. Notamment, l'analyse quantitative de l'interaction DAP5-eIF4A par calorimétrie de titration isotherme révèle une affinité 10 fois plus faible que l'interaction eIF4G-eIF4A, ce qui semble affecter la capacité de DAP5 à stimuler l'activité hélicasique d'eIF4A in vitro. Cette différence dans la stabilité du complexe pourrait être impliquée dans la sélection du mode d'initiation de la traduction. vi Table of contents List of abbreviations..........................................................................................................iii Abstract................................................................................................................................v Résumé ..............................................................................................................................vi Table of contents...............................................................................................................vii List of tables and figures..................................................................................................ix Preface..................................................................................................................................x Acknowledgements.............................................................................................................xi Prologue: Regulation of gene expression from DNA to protein..........................................1 Chapter 1: Basic concepts in the study of translation initiation 1 Translation........................................................................................................................4 1.1 Eukaryotic translation initiation.....................................................................................6 1.1.1 Anatomy of the mRNA...................................................................................6 1.1.2 General mechanism of eukaryotic translation initiation.................................7 1.1.3 Components of eIF4F.....................................................................................9 1.1.3.1 Regulation of eIF4F.........................................................................9 1.1.3.2 eIF4E..............................................................................................10 1.1.3.3 eIF4G.............................................................................................10 1.1.3.4 eIF4A.............................................................................................14 1.2 The versatility of eIF4G family and eIF4G-like proteins............................................18 1.2.1 Occurrence of eIF4G domains in other proteins...........................................18 1.2.2 Role of the MA3 domain of eIF4G...............................................................19 1.2.3 Alternative modes of ribosome recruitment.................................................23 1.2.3.1 Viral infection ...............................................................................23 1.2.3.2 Cap-independent translation of cellular mRNAs...........................24 1.3 Death-Associated-Protein 5 (DAP5)............................................................................27 1.3.1 Topology of DAP5........................................................................................27 1.3.2 Function in cap-independent translation initiation.......................................28 1.3.3 Three-dimensional structure.........................................................................30 vii 1.4 Rationale of the study..................................................................................................32 Chapter 2: Structural analysis of the DAP5 MIF4G domain and its interaction with eIF4A 2.1 Introduction..................................................................................................................34 2.2 Results..........................................................................................................................38 2.2.1 Overall structure of the DAP5 MIF4G domain, or DAP5M........................38 2.2.2 Comparison of DAP5M and eIF4G MIF4G domains...................................42 2.2.3 Identification of a potential IRES binding site in DAP5M...........................43 2.2.4 The sites of interaction with eIF4A are structurally conserved in the middle domains of eIF4G and DAP5 but have different binding affinities.......................47 2.2.5 Mutational analysis of Site 1 and Site 2 residues in the DAP5-eIF4A complex..................................................................................................................50 2.2.6 Effect of DAP5M on the helicase activity....................................................53 2.3 Discussion....................................................................................................................55 2.4 Materials and methods.................................................................................................56 2.4.1 Expression and purification of recombinant proteins...................................56 2.4.2 Mutagenesis of DAP5M...............................................................................58 2.4.3 Crystallization and data collection................................................................58 2.4.4 Structure determination.................................................................................58 2.4.5 Gel filtration chromatography.......................................................................59 2.4.6 In vitro pull-down
Recommended publications
  • AVILA-DISSERTATION.Pdf
    LOGOS EX MACHINA: A REASONED APPROACH TOWARD CANCER by Andrew Avila, B. S., M. S. A Dissertation In Biological Sciences Submitted to the Graduate Faculty of Texas Tech University in Partial Fulfillment of the Requirements for the Degree of Doctor of Philosophy Approved Lauren Gollahon Chairperson of the Committee Rich Strauss Sean Rice Boyd Butler Richard Watson Peggy Gordon Miller Dean of the Graduate School May, 2012 c 2012, Andrew Avila Texas Tech University, Andrew Avila, May 2012 ACKNOWLEDGEMENTS I wish to acknowledge the incredible support given to me by my major adviser, Dr. Lauren Gollahon. Without your guidance surely I would not have made it as far as I have. Furthermore, the intellectual exchange I have shared with my advisory committee these long years have propelled me to new heights of inquiry I had not dreamed of even in the most lucid of my imaginings. That their continual intellectual challenges have provoked and evoked a subtle sense of natural wisdom is an ode to their efficacy in guiding the aspirant to the well of knowledge. For this initiation into the mysteries of nature I cannot thank my advisory committee enough. I also wish to thank the Vice President of Research for the fellowship which sustained the initial couple years of my residency at Texas Tech. Furthermore, my appreciation of the support provided to me by the Biology Department, financial and otherwise, cannot be understated. Finally, I also wish to acknowledge the individuals working at the High Performance Computing Center, without your tireless support in maintaining the cluster I would have not have completed the sheer amount of research that I have.
    [Show full text]
  • Genetic Signatures of High-Altitude Adaptation and Geographic
    www.nature.com/scientificreports OPEN Genetic signatures of high‑altitude adaptation and geographic distribution in Tibetan sheep Jianbin Liu1,2*, Chao Yuan1,2, Tingting Guo1,2, Fan Wang3, Yufeng Zeng1, Xuezhi Ding1, Zengkui Lu1,2, Dingkao Renqing4, Hao Zhang5, Xilan Xu6, Yaojing Yue1,2, Xiaoping Sun1,2, Chune Niu1,2, Deqing Zhuoga7* & Bohui Yang1,2* Most sheep breeding programs designed for the tropics and sub‑tropics have to take into account the impacts of environmental adaptive traits. However, the genetic mechanism regulating the multiple biological processes driving adaptive responses remains unclear. In this study, we applied a selective sweep analysis by combing 1% top values of Fst and ZHp on both altitude and geographic subpopulations (APS) in 636 indigenous Tibetan sheep breeds. Results show that 37 genes were identifed within overlapped genomic regions regarding Fst signifcantly associated with APS. Out of the 37 genes, we found that 8, 3 and 6 genes at chromosomes (chr.) 13, 23 and 27, respectively, were identifed in the genomic regions with 1% top values of ZHp. We further analyzed the INDEL variation of 6 genes at chr.27 (X chromosome) in APS together with corresponding orthologs of 6 genes in Capra, Pantholops, and Bos Taurus. We found that an INDEL was located within 5′UTR region of HAG1 gene. This INDEL of HAG1 was strongly associated with the variation of APS, which was further confrmed by qPCR. Sheep breeds carrying “C‑INDEL” of HAG1 have signifcantly greater body weight, shear amount, corpuscular hemoglobin and globulin levels, but lower body height, than those carrying “CA‑INDEL” of HAG1.
    [Show full text]
  • Crystal Structure of a Variant PAM2 Motif of LARP4B Bound to the MLLE Domain of PABPC1
    biomolecules Article Crystal Structure of a Variant PAM2 Motif of LARP4B Bound to the MLLE Domain of PABPC1 Clemens Grimm *, Jann-Patrick Pelz, Cornelius Schneider, Katrin Schäffler and Utz Fischer Department of Biochemistry, Theodor Boveri Institute, Biocenter of the University of Würzburg, 97070 Würzburg, Germany; [email protected] (J.-P.P.); [email protected] (C.S.); katrin.schaeffl[email protected] (K.S.); utz.fi[email protected] (U.F.) * Correspondence: [email protected] Received: 3 April 2020; Accepted: 4 June 2020; Published: 6 June 2020 Abstract: Eukaryotic cells determine the protein output of their genetic program by regulating mRNA transcription, localization, translation and turnover rates. This regulation is accomplished by an ensemble of RNA-binding proteins (RBPs) that bind to any given mRNA, thus forming mRNPs. Poly(A) binding proteins (PABPs) are prominent members of virtually all mRNPs that possess poly(A) tails. They serve as multifunctional scaffolds, allowing the recruitment of diverse factors containing a poly(A)-interacting motif (PAM) into mRNPs. We present the crystal structure of the variant PAM motif (termed PAM2w) in the N-terminal part of the positive translation factor LARP4B, which binds to the MLLE domain of the poly(A) binding protein C1 cytoplasmic 1 (PABPC1). The structural analysis, along with mutational studies in vitro and in vivo, uncovered a new mode of interaction between PAM2 motifs and MLLE domains. Keywords: PAM2w; PAM2; PABC1; MLLE domain; PABP; Poly(A) binding protein 1. Introduction In higher eukaryotes, posttranscriptional mechanisms contribute significantly to gene expression. The mRNA, which is translated into proteins by the ribosomes, has first to undergo several maturation steps, from the primary pre-mRNA transcript to the mature mRNA.
    [Show full text]
  • Novelty Indicator for Enhanced Prioritization of Predicted Gene Ontology Annotations
    IEEE/ACM TRANSACTIONS ON COMPUTATIONAL BIOLOGY AND BIOINFORMATICS, VOL. X, NO. X, MONTHXXX 20XX 1 Novelty Indicator for Enhanced Prioritization of Predicted Gene Ontology Annotations Davide Chicco, Fernando Palluzzi, and Marco Masseroli Abstract—Biomolecular controlled annotations have become pivotal in computational biology, because they allow scientists to analyze large amounts of biological data to better understand their test results, and to infer new knowledge. Yet, biomolecular annotation databases are incomplete by definition, like our knowledge of biology, and may contain errors and inconsistent information. In this context, machine-learning algorithms able to predict and prioritize new biomolecular annotations are both effective and efficient, especially if compared with the time-consuming trials of biological validation. To limit the possibility that these techniques predict obvious and trivial high-level features, and to help prioritizing their results, we introduce here a new element that can improve the accuracy and relevance of the results of an annotation prediction and prioritization pipeline. We propose a novelty indicator able to state the level of ”newness” (or ”originality”) of the annotations predicted for a specific gene to Gene Ontology terms, and to help prioritizing the most novel and interesting annotations predicted. We performed a thorough biological functional analysis of the prioritized annotations predicted with high accuracy by using this indicator and our previously proposed prediction algorithms. The relevance
    [Show full text]
  • Clinical Impact of Copy Number Variation Changes in Bladder Cancer Samples
    EXPERIMENTAL AND THERAPEUTIC MEDICINE 22: 901, 2021 Clinical impact of copy number variation changes in bladder cancer samples VICTORIA SPASOVA1, BORIS MLADENOV2, SIMEON RANGELOV3, ZORA HAMMOUDEH1, DESISLAVA NESHEVA1, DIMITAR SERBEZOV1, RADA STANEVA1,4, SAVINA HADJIDEKOVA1,4, MIHAIL GANEV1, LUBOMIR BALABANSKI1,5, RADOSLAVA VAZHAROVA5,6, CHAVDAR SLAVOV3, DRAGA TONCHEVA1 and OLGA ANTONOVA1 1Department of Medical Genetics, Medical University‑Sofia, 1431 Sofia;2 Department of Urology, UMBALSM N.I. Pirogov, 1606 Sofia; 3Department of Urology, Tsaritsa Yoanna University Hospital, 1527 Sofia; 4Medical Genetics Laboratory, Nadezhda Women's Health Hospital, 1373 Sofia; 5Medical Genetics Laboratory, GARH Malinov, 1680 Sofia; 6Department of Biology, Medical Genetics and Microbiology, Faculty of Medicine, Sofia University St. Kliment Ohridski, 1407 Sofia, Bulgaria Received November 30, 2019; Accepted February 18, 2021 DOI: 10.3892/etm.2021.10333 Abstract. The aim of the present study was to detect copy uroepithelial tumours may lay a foundation for implementing number variations (CNVs) related to tumour progression and molecular CNV profiling of bladder tumours as part of a metastasis of urothelial carcinoma through whole‑genome routine progression risk estimation strategy, thus expanding scanning. A total of 30 bladder cancer samples staged from the personalized therapeutic approach. pTa to pT4 were included in the study. DNA was extracted from freshly frozen tissue via standard phenol‑chloroform extraction Introduction and CNV analysis was performed on two alternative platforms (CytoChip Oligo aCGH, 4x44K and Infinium OncoArray‑500K The most successful approach to treating a disease has BeadChip; Illumina, Inc.). Data were analysed with BlueFuse always been etiological therapy. In the case of bladder Multi software and Karyostudio, respectively.
    [Show full text]
  • Protein Tyrosine Phosphorylation in Haematopoietic Cancers and the Functional Significance of Phospho- Lyn SH2 Domain
    Protein Tyrosine Phosphorylation in Haematopoietic Cancers and the Functional Significance of Phospho- Lyn SH2 Domain By Lily Li Jin A thesis submitted in conformity with the requirements for the degree of Ph.D. in Molecular Genetics, Graduate Department of Molecular Genetics, in the University of Toronto © Copyright by Lily Li Jin (2015) Protein Tyrosine Phosphorylation in Haematopoietic Cancers and the Functional Significance of Phospho-Lyn SH2 Domain Lily Li Jin 2015 Ph.D. in Molecular Genetics Graduate Department of Molecular Genetics University of Toronto Abstract Protein-tyrosine phosphorylation (pY) is a minor but important protein post-translational modification that modulates a wide range of cellular functions and is involved in cancer. Dysregulation of tyrosine kinases (TKs) and protein-tyrosine phosphatases (PTPs) have been observed in multiple myeloma (MM) and acute myeloid leukemia (AML) and is a subject of study. Using recently developed mass spectrometry-based proteomics techniques, quantitative PTP expression and cellular pY profiles were generated for MM cell lines and mouse xenograft tumors, as well as primary AML samples. Integrated comprehensive analyses on these data implicated a subset of TKs and PTPs in MM and AML, with valuable insights gained on the dynamic regulation of pY in biological systems. In particular, I propose a model that describes the cellular pY state as a functional output of the total activated TKs and PTPs in the cell. My results show that the global pY profile in the cancer models is quantitatively related to the cellular levels of activated TKs and PTPs. Furthermore, the identity of the implicated TK/PTPs is system- ii dependent, demonstrating context-dependent regulation of pY.
    [Show full text]
  • Molecular Targeting and Enhancing Anticancer Efficacy of Oncolytic HSV-1 to Midkine Expressing Tumors
    University of Cincinnati Date: 12/20/2010 I, Arturo R Maldonado , hereby submit this original work as part of the requirements for the degree of Doctor of Philosophy in Developmental Biology. It is entitled: Molecular Targeting and Enhancing Anticancer Efficacy of Oncolytic HSV-1 to Midkine Expressing Tumors Student's name: Arturo R Maldonado This work and its defense approved by: Committee chair: Jeffrey Whitsett Committee member: Timothy Crombleholme, MD Committee member: Dan Wiginton, PhD Committee member: Rhonda Cardin, PhD Committee member: Tim Cripe 1297 Last Printed:1/11/2011 Document Of Defense Form Molecular Targeting and Enhancing Anticancer Efficacy of Oncolytic HSV-1 to Midkine Expressing Tumors A dissertation submitted to the Graduate School of the University of Cincinnati College of Medicine in partial fulfillment of the requirements for the degree of DOCTORATE OF PHILOSOPHY (PH.D.) in the Division of Molecular & Developmental Biology 2010 By Arturo Rafael Maldonado B.A., University of Miami, Coral Gables, Florida June 1993 M.D., New Jersey Medical School, Newark, New Jersey June 1999 Committee Chair: Jeffrey A. Whitsett, M.D. Advisor: Timothy M. Crombleholme, M.D. Timothy P. Cripe, M.D. Ph.D. Dan Wiginton, Ph.D. Rhonda D. Cardin, Ph.D. ABSTRACT Since 1999, cancer has surpassed heart disease as the number one cause of death in the US for people under the age of 85. Malignant Peripheral Nerve Sheath Tumor (MPNST), a common malignancy in patients with Neurofibromatosis, and colorectal cancer are midkine- producing tumors with high mortality rates. In vitro and preclinical xenograft models of MPNST were utilized in this dissertation to study the role of midkine (MDK), a tumor-specific gene over- expressed in these tumors and to test the efficacy of a MDK-transcriptionally targeted oncolytic HSV-1 (oHSV).
    [Show full text]
  • The Changing Chromatome As a Driver of Disease: a Panoramic View from Different Methodologies
    The changing chromatome as a driver of disease: A panoramic view from different methodologies Isabel Espejo1, Luciano Di Croce,1,2,3 and Sergi Aranda1 1. Centre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology, Dr. Aiguader 88, Barcelona 08003, Spain 2. Universitat Pompeu Fabra (UPF), Barcelona, Spain 3. ICREA, Pg. Lluis Companys 23, Barcelona 08010, Spain *Corresponding authors: Luciano Di Croce ([email protected]) Sergi Aranda ([email protected]) 1 GRAPHICAL ABSTRACT Chromatin-bound proteins regulate gene expression, replicate and repair DNA, and transmit epigenetic information. Several human diseases are highly influenced by alterations in the chromatin- bound proteome. Thus, biochemical approaches for the systematic characterization of the chromatome could contribute to identifying new regulators of cellular functionality, including those that are relevant to human disorders. 2 SUMMARY Chromatin-bound proteins underlie several fundamental cellular functions, such as control of gene expression and the faithful transmission of genetic and epigenetic information. Components of the chromatin proteome (the “chromatome”) are essential in human life, and mutations in chromatin-bound proteins are frequently drivers of human diseases, such as cancer. Proteomic characterization of chromatin and de novo identification of chromatin interactors could thus reveal important and perhaps unexpected players implicated in human physiology and disease. Recently, intensive research efforts have focused on developing strategies to characterize the chromatome composition. In this review, we provide an overview of the dynamic composition of the chromatome, highlight the importance of its alterations as a driving force in human disease (and particularly in cancer), and discuss the different approaches to systematically characterize the chromatin-bound proteome in a global manner.
    [Show full text]
  • PABPC1 Antibody (Center) Purified Rabbit Polyclonal Antibody (Pab) Catalog # Ap2920c
    10320 Camino Santa Fe, Suite G San Diego, CA 92121 Tel: 858.875.1900 Fax: 858.622.0609 PABPC1 Antibody (Center) Purified Rabbit Polyclonal Antibody (Pab) Catalog # AP2920c Specification PABPC1 Antibody (Center) - Product Information Application WB, IHC-P,E Primary Accession P11940 Other Accession Q6IP09, P20965, Q9EPH8, P29341, P61286 Reactivity Human, Mouse Predicted Bovine, Rat, Xenopus Host Rabbit Clonality Polyclonal Isotype Rabbit Ig Calculated MW 70671 Antigen Region 250-279 Western blot analysis of PABPC1 Antibody PABPC1 Antibody (Center) - Additional (Center) (Cat. #AP2920c) in NIH-3T3 cell line Information lysates (35ug/lane). PABPC1 (arrow) was detected using the purified Pab. Gene ID 26986 Other Names Polyadenylate-binding protein 1, PABP-1, Poly(A)-binding protein 1, PABPC1, PAB1, PABP1, PABPC2 Target/Specificity This PABPC1 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 250-279 amino acids from the Central region of human PABPC1. Dilution Formalin-fixed and paraffin-embedded WB~~1:1000 human lung carcinoma reacted with PABPC1 IHC-P~~1:50~100 Antibody (Center), which was peroxidase-conjugated to the secondary Format antibody, followed by DAB staining. This data Purified polyclonal antibody supplied in PBS demonstrates the use of this antibody for with 0.09% (W/V) sodium azide. This immunohistochemistry; clinical relevance has antibody is prepared by Saturated not been evaluated. Ammonium Sulfate (SAS) precipitation followed by dialysis against PBS. PABPC1 Antibody (Center) - Background Storage Maintain refrigerated at 2-8°C for up to 2 PABPC1 binds the poly(A) tail of mRNA. It may weeks. For long term storage store at -20°C be involved in cytoplasmic regulatory Page 1/3 10320 Camino Santa Fe, Suite G San Diego, CA 92121 Tel: 858.875.1900 Fax: 858.622.0609 in small aliquots to prevent freeze-thaw processes of mRNA metabolism such as cycles.
    [Show full text]
  • Poly(A)-Binding Proteins: Structure, Domain Organization, and Activity Regulation
    ISSN 0006-2979, Biochemistry (Moscow), 2013, Vol. 78, No. 13, pp. 1377-1391. © Pleiades Publishing, Ltd., 2013. Published in Russian in Uspekhi Biologicheskoi Khimii, 2013, Vol. 53, pp. 3-34. REVIEW Poly(A)-Binding Proteins: Structure, Domain Organization, and Activity Regulation I. A. Eliseeva, D. N. Lyabin, and L. P. Ovchinnikov* Institute of Protein Research, Russian Academy of Sciences, 142290 Pushchino, Moscow Region, Russia; E-mail: [email protected]; [email protected]; [email protected] Received May 6, 2013 Abstract—RNA-binding proteins are of vital importance for mRNA functioning. Among these, poly(A)-binding proteins (PABPs) are of special interest due to their participation in virtually all mRNA-dependent events that is caused by their high affinity for A-rich mRNA sequences. Apart from mRNAs, PABPs interact with many proteins, thus promoting their involvement in cellular events. In the nucleus, PABPs play a role in polyadenylation, determine the length of the poly(A) tail, and may be involved in mRNA export. In the cytoplasm, they participate in regulation of translation initiation and either protect mRNAs from decay through binding to their poly(A) tails or stimulate this decay by promoting mRNA inter- actions with deadenylase complex proteins. This review presents modern notions of the role of PABPs in mRNA-depend- ent events; peculiarities of regulation of PABP amount in the cell and activities are also discussed. DOI: 10.1134/S0006297913130014 Key words: PABPs, mRNA, translation, poly(A) tail, polyadenylation, mRNA decay Poly(A)-binding proteins (PABPs) are a highly con- Historically, the first poly(A)-binding protein was served class of eukaryotic RNA-binding proteins that discovered as a major protein of cytoplasmic mRNPs [1] specifically recognize the polyadenylic acid sequence showing an elevated affinity for a poly(A) sequence [2].
    [Show full text]
  • Functional Genomics Identifies New Synergistic Therapies For
    Oncogene (2020) 39:5338–5357 https://doi.org/10.1038/s41388-020-1372-7 ARTICLE Functional genomics identifies new synergistic therapies for retinoblastoma 1,2 1,2,3 1 3,4 1 Arthur Aubry ● Joel D. Pearson ● Katherine Huang ● Izhar Livne-bar ● Mohammad Ahmad ● 5,9 6 7 7 1 1 Madhavan Jagadeesan ● Vikas Khetan ● Troy Ketela ● Kevin R. Brown ● Tao Yu ● Suying Lu ● 1,8 7,8 1,2,3 Jeffrey L. Wrana ● Jason Moffat ● Rod Bremner Received: 23 March 2020 / Revised: 3 June 2020 / Accepted: 12 June 2020 / Published online: 22 June 2020 © The Author(s) 2020. This article is published with open access Abstract Local intravitreal or intra-arterial chemotherapy has improved therapeutic success for the pediatric cancer retinoblastoma (RB), but toxicity remains a major caveat. RB initiates primarily with RB1 loss or, rarely, MYCN amplification, but the critical downstream networks are incompletely understood. We set out to uncover perturbed molecular hubs, identify synergistic drug combinations to target these vulnerabilities, and expose and overcome drug resistance. We applied dynamic transcriptomic analysis to identify network hubs perturbed in RB versus normal fetal retina, and performed in vivo RNAi screens in RB1null and RB1wt;MYCNamp orthotopic xenografts to pinpoint essential hubs. We employed in vitro and in vivo studies to validate hits, define mechanism, develop new therapeutic modalities, and understand drug resistance. We 1234567890();,: 1234567890();,: identified BRCA1 and RAD51 as essential for RB cell survival. Their oncogenic activity was independent of BRCA1 functions in centrosome, heterochromatin, or ROS regulation, and instead linked to DNA repair. RAD51 depletion or inhibition with the small molecule inhibitor, B02, killed RB cells in a Chk1/Chk2/p53-dependent manner.
    [Show full text]
  • A Two-Color Haploid Genetic Screen Identifies Novel Host Factors Involved in HIV Latency
    bioRxiv preprint doi: https://doi.org/10.1101/2021.01.20.427543; this version posted January 22, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. A two-color haploid genetic screen identifies novel host factors involved in HIV latency Running Title: Identification of novel HIV latency host factors. Authors: Michael D Röling1, Mahsa Mollapour Sisakht1#, Enrico Ne1#, Panagiotis Moulos2#, Mateusz Stoszko1, Elisa De Crignis1, Helen Bodmer1, Tsung Wai Kan1, Maryam Akbarzadeh1, Vaggelis Harokopos2, Pantelis Hatzis2, Robert-Jan Palstra1*, Tokameh Mahmoudi1* # authors contributed equally Affiliations: 1 Department of Biochemistry, Erasmus University Medical Center, Ee634 PO Box 2040 3000CA Rotterdam, the Netherlands 2 Institute for Fundamental Biomedical Research, Biomedical Sciences Research Center, Alexander Fleming', Fleming, Fleming Street 34, 16672, Vari, Greece * Correspondence to: Tokameh Mahmoudi: [email protected], Phone N: +31 (0)107043324, Fax N: +31(0)10704747 Robert-Jan Palstra: [email protected] Phone N: +31 (0)107043323, Fax N: +31(0)10704747 1 bioRxiv preprint doi: https://doi.org/10.1101/2021.01.20.427543; this version posted January 22, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. Abstract To identify novel host factors as putative targets to reverse HIV latency, we performed an insertional mutagenesis genetic screen in a latently HIV-1-infected pseudo-haploid KBM7 cell line (Hap-Lat).
    [Show full text]